MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

Search

Zoetis Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

161.75 -1.67

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

161.14

Max

165.54

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-101M

581M

Pardavimai

-83M

2.3B

P/E

Sektoriaus vid.

30.101

63.778

Pelnas, tenkantis vienai akcijai

1.4

Dividendų pajamingumas

1.21

Pelno marža

25.076

Darbuotojai

13,800

EBITDA

-133M

906M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+28.29% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

1.21%

2.39%

Kitas uždarbis

2025-05-06

Kita Ex Dividend data

2025-04-21

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-5.1B

74B

Ankstesnė atidarymo kaina

163.42

Ankstesnė uždarymo kaina

161.75

Naujienos nuotaikos

By Acuity

37%

63%

123 / 386 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Strong Bearish Evidence

Zoetis Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2024-11-04 12:47; UTC

Uždarbis

Zoetis Lifts Guidance On Strong Demand as 3Q Beats Market Views

2024-08-06 11:52; UTC

Uždarbis

Zoetis Raises Guidance After 2Q Sales, Earnings Rise

2025-02-20 08:00; UTC

Svarbiausios naujienos

A Bird-Flu Vaccine Could Bring Down Egg Prices. Why the Poultry Industry Is Fighting It. -- Barrons.com

2025-02-13 13:47; UTC

Uždarbis

Zoetis Plunges 9% As 2025 Guidance Misses Expectations -- IBD

2025-02-13 12:09; UTC

Uždarbis

Zoetis Sees FY25 Adj EPS $6-Adj EPS $6.10 >ZTS

2025-02-13 12:08; UTC

Uždarbis

Zoetis Sees FY25 Rev $9.225B-$9.375B >ZTS

2025-02-13 12:08; UTC

Uždarbis

Zoetis Sees FY25 EPS $5.70-EPS $5.80 >ZTS

2025-02-13 12:00; UTC

Uždarbis

Zoetis 4Q EPS $1.29 >ZTS

2025-02-13 12:00; UTC

Uždarbis

Zoetis 4Q Rev $2.32B >ZTS

2025-02-13 12:00; UTC

Uždarbis

Zoetis 4Q Net $581M >ZTS

2024-11-04 14:05; UTC

Uždarbis

Zoetis Barks Up A Third-Quarter Beat And Raise, But Stock Slips -- IBD

2024-11-04 12:06; UTC

Uždarbis

Zoetis Sees 2024 Rev $9.2B-$9.3B >ZTS

2024-11-04 12:06; UTC

Uždarbis

Zoetis Sees 2024 Adj EPS $5.86-Adj EPS $5.92 >ZTS

2024-11-04 12:05; UTC

Uždarbis

Zoetis 3Q Adj EPS $1.58 >ZTS

2024-11-04 12:00; UTC

Uždarbis

Zoetis 3Q Net $682M >ZTS

2024-11-04 12:00; UTC

Uždarbis

Zoetis 3Q EPS $1.50 >ZTS

2024-11-04 12:00; UTC

Uždarbis

Zoetis 3Q Rev $2.39B >ZTS

2024-08-06 11:44; UTC

Uždarbis

Zoetis Earnings Growth Picks Up, Tops Views -- IBD

2024-08-06 11:09; UTC

Uždarbis

Zoetis Raises 2024 Operational Revenue Growth View to 9%-11% >ZTS

2024-08-06 11:08; UTC

Uždarbis

Zoetis Raises 2024 View To Adj EPS $5.78-Adj EPS $5.88 >ZTS

2024-08-06 11:08; UTC

Uždarbis

Zoetis Raises 2024 View To Rev $9.1B-$9.25B >ZTS

2024-08-06 11:08; UTC

Uždarbis

Zoetis 2Q Adj EPS $1.56 >ZTS

2024-08-06 11:00; UTC

Uždarbis

Zoetis 2Q Net $624M >ZTS

2024-08-06 11:00; UTC

Uždarbis

Zoetis 2Q Rev $2.36B >ZTS

2024-08-06 11:00; UTC

Uždarbis

Zoetis 2Q EPS $1.37 >ZTS

2024-05-02 17:43; UTC

Uždarbis

Zoetis Stock Climbs on Earnings Beat, but Worries Linger Over Key Medicine -- Barrons.com

2024-05-02 13:06; UTC

Uždarbis

Zoetis Stock Climbs on Earnings Beat, but Worries Linger Over Key Medicine -- Barrons.com

2024-05-02 11:27; UTC

Uždarbis

Zoetis Earnings Top; Pet Drugmaker Rises -- IBD

2024-05-02 11:00; UTC

Uždarbis

Zoetis 1Q Net $599M >ZTS

2024-05-02 11:00; UTC

Uždarbis

Zoetis 1Q EPS $1.31 >ZTS

Akcijų palyginimas

Kainos pokytis

Zoetis Inc Prognozė

Kainos tikslas

By TipRanks

28.29% į viršų

12 mėnesių prognozė

Vidutinis 207.71 USD  28.29%

Aukščiausias 242 USD

Žemiausias 180 USD

Remiantis 8 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Zoetis Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

8 ratings

7

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

161.695 / 163.24Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Strong Bearish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

Strong Bearish Evidence

Rinkos nuotaikos

By Acuity

123 / 386 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Zoetis Inc

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.